Myron Kaplan - 16 Nov 2021 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Director
Signature
/s/ Myron Kaplan
Issuer symbol
CRMD
Transactions as of
16 Nov 2021
Net transactions value
+$51,400
Form type
4
Filing time
19 Nov 2021, 15:45:58 UTC
Previous filing
19 May 2021
Next filing
29 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRMD Common Stock Purchase $51,400 +10,000 +6.1% $5.14 175,034 16 Nov 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CRMD Stock Option (Right to Buy Common Stock) 30,000 16 Nov 2021 Common Stock 30,000 $8.32 Direct F1
holding CRMD Stock Option (Right to Buy Common Stock) 15,000 16 Nov 2021 Common Stock 15,000 $5.63 Direct F2
holding CRMD Stock Option (Right to Buy Common Stock) 15,000 16 Nov 2021 Common Stock 15,000 $8.30 Direct F3
holding CRMD Stock Option (Right to Buy Common Stock) 8,000 16 Nov 2021 Common Stock 8,000 $2.85 Direct F4
holding CRMD Stock Option (Right to Buy Common Stock) 8,000 16 Nov 2021 Common Stock 8,000 $11.20 Direct F5
holding CRMD Stock Option (Right to Buy Common Stock) 10,000 16 Nov 2021 Common Stock 10,000 $21.40 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted on 1/11/2021. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.
F2 These options were granted on 02/25/2020. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.
F3 These options were granted on 01/10/2019. These options are fully vested.
F4 These options were granted on 02/16/2018. These options are fully vested.
F5 These options were granted on 02/21/2017. These options are fully vested.
F6 These options were granted on 4/28/2016. These options are fully vested.

Remarks:

The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split.